Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A form of endogenous Cushing syndrome characterized by chronic over-secretion of cortisol due to a benign adrenal tumor that arises from the adrenal cortex.
Biomarker and diagnostic research for Cushing syndrome due to cortisol-producing adrenocortical adenoma has been reported in the published literature.
No clinical trials have been registered for Cushing syndrome due to cortisol-producing adrenocortical adenoma.
18 publications have been identified in PubMed for Cushing syndrome due to cortisol-producing adrenocortical adenoma. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (28%), and Diagnostic / Biomarker (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 6 | 33% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:37 PM UTC
European rare disease database
Common questions about Cushing syndrome due to cortisol-producing adrenocortical adenoma
Patient case studies |
5 |
28% |
Testing and diagnosis research | 3 | 17% |
Laboratory research | 3 | 17% |
Disease patterns and progression | 1 | 6% |
Yanase T (2026). [PMID: 40707183](https://pubmed.ncbi.nlm.nih.gov/40707183/). *Endocr J*. [Review / Meta-Analysis]
Wada N (2026). [PMID: 40967826](https://pubmed.ncbi.nlm.nih.gov/40967826/). *Endocr J*. [Review / Meta-Analysis]
Kanzawa M (2026). [PMID: 42158162](https://pubmed.ncbi.nlm.nih.gov/42158162/). *JCEM Case Rep*. [Case Report / Case Series]
Nagano E (2026). [PMID: 42126596](https://pubmed.ncbi.nlm.nih.gov/42126596/). *Anal Bioanal Chem*. [Diagnostic / Biomarker]
Ito F (2026). [PMID: 42022169](https://pubmed.ncbi.nlm.nih.gov/42022169/). *IJU Case Rep*. [Case Report / Case Series]
Yang Q (2025). [PMID: 40544411](https://pubmed.ncbi.nlm.nih.gov/40544411/). *Metabolomics*. [Diagnostic / Biomarker]
Wang M (2025). [PMID: 40926611](https://pubmed.ncbi.nlm.nih.gov/40926611/). *Mini Rev Med Chem*. [Review / Meta-Analysis]
Jamaluddin A (2025). [PMID: 40391091](https://pubmed.ncbi.nlm.nih.gov/40391091/). *Endocr Oncol*. [Basic Science / Preclinical]
Xu M (2025). [PMID: 39891827](https://pubmed.ncbi.nlm.nih.gov/39891827/). *J Endocrinol Invest*. [Diagnostic / Biomarker]
Li Q (2025). [PMID: 41106389](https://pubmed.ncbi.nlm.nih.gov/41106389/). *Stem Cell Reports*. [Basic Science / Preclinical]